Antibody responses to M.tb antigens, specifically IgG against TBCM and CFP-10, and IgG and IgA against Ag85B, can effectively distinguish between active tuberculosis (ATB), latent tuberculosis infection (LTBI), and non-infected individuals, providing a potential biomarker for M.tb infection (86). Here, CD79A is linked to tuberculosis.